Intrigued by the $10M targetLike many here, I'm guessing it's going to be an extremely embarrassing PP given the recent muted raises, or, a guaranteed source who's going to mop up whatever's left on the offer on the 21st. Just hoping that it's not the former, where Theralase drank their own Koolaid after releasing back to back NRs about the potential for Ruvidar, and assumed investors will suddenly forget past hiccups. Bought a few thousand. We'll know in 4 days or earlier. Keeping expectations (very) low.